High Point Advisor Group LLC Gilead Sciences, Inc. Transaction History
High Point Advisor Group LLC
- $1.75 Billion
- Q4 2024
A detailed history of High Point Advisor Group LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, High Point Advisor Group LLC holds 18,962 shares of GILD stock, worth $2.09 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
18,962
Previous 19,650
3.5%
Holding current value
$2.09 Million
Previous $1.65 Million
6.31%
% of portfolio
0.1%
Previous 0.1%
Shares
19 transactions
Others Institutions Holding GILD
# of Institutions
2,101Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.7 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.9 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.66 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.39 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...